ESC 365 - Accuracy of nine artificial intelligence chatbots in replying in accordance with the 2023 ESH guidelines for the management of arterial hypertension

Open Access

Accuracy of nine artificial intelligence chatbots in replying in accordance with the 2023 ESH guidelines for the management of arterial hypertension

Session: Poster session 1 - Managing cardiovascular risk: pharmacological and digital tools

Topic: Artificial Intelligence (Machine Learning, Deep Learning)

Speaker: Mr D. Tsounis (Nea Makri, GR)

Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

About the speaker

Mr Dimitrios Tsounis

Nea Makri (Greece)

0 follower

5 more presentations in this session

Discussants - Managing cardiovascular risk: pharmacological and digital tools

Effect of statins on thoracic aortic disease: results from a meta-analysis and experimental data

Speaker: Doctor P. Poggio (Milan, IT)

The CV polypill strategy (acetyl salicylic acid + atorvastatin + ramipril) as baseline treatment after a cardiovascular event supported by recent compelling evidence: a global expert consensus

Speaker: Professor A. Abreu (Lisbon, PT)

Percentage and main features of patients referred to a cardiac rehabilitation program who would have an indication for a GLP1 receptor agonist based on the SELECT trial criteria

Speaker: Doctor J. Torres Marques (Palma de Mallorca, ES)

Effect of SGLT2 inhibitors in the management of moroccan patients with heart failure with reduced ejection fraction

Speaker: Professor N. Mouine (Rabat, MA)

Access the full session

Poster session 1 - Managing cardiovascular risk: pharmacological and digital tools

Speakers: Mr D. Tsounis, Doctor P. Poggio, Professor A. Abreu, Doctor J. Torres Marques, Professor N. Mouine

About the event

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources